Z-1734-2023 Class I Ongoing
FDA device recall Z-1734-2023 was initiated by Medtronic Inc., Cardiac Rhythm And Heart Failure (CRHF) on May 10, 2023 and is designated Class I. Reason for recall: There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy… The recall status is ongoing. Affected quantity: 14 units.
Recall details
- Product Type
- Devices
- Report Date
- Jun 28, 2023
- Initiation Date
- May 10, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 14 units
Product description
CRTD VIVA QUAD XT CUST PARY GOLD, Model Number DTBA1QQPG; Implantable Cardioverter Defibrillators
Reason for recall
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) manufactured with a specific (glassed) feedthrough, including currently available ICDs and CRT-Ds.
Distribution pattern
US Nationwide - Worldwide Distribution
Code information
GTIN 00643169968585, Lot Serial Numbers: BLC229283H, BLC229226H, BLC229270H, BLC229280H, BLC229229H, BLC228997H, BLC229238H, BLC229043H, BLC229231H, BLC229046H, BLC229045H, BLC229230H, BLC228995H, BLC229010H
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1734-2023
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026